STOCK TITAN
  1. Home
  2. Sec-filings
  3. INDV
  4. [ARS] Indivior Pharmaceuticals, Inc. SEC Filing

[ARS] Indivior Pharmaceuticals, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - Indivior Pharmaceuticals, Inc.

ARS Filing - Indivior Pharmaceuticals, Inc.

This filing is available as a PDF document.

Filing Type: ARS

Company: Indivior Pharmaceuticals, Inc. (INDV)

Acceptance Date: 2026-03-27T06:11:47.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Indivior Pharmaceuticals Inc.

NASDAQ:INDV

View INDV Stock Overview →

INDV Rankings

#1660 Ranked by Market Cap
N/A Ranked by Dividends

INDV Latest News

Mar 31, 2026
New Cost Impact Model Highlights Potential for Monthly Injectable Buprenorphine to Reduce Staffing Burdens in Correctional Facilities
Mar 17, 2026
National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use Disorder
Mar 12, 2026
Indivior Prices Upsized $450.0 Million Convertible Senior Notes Offering
Mar 12, 2026
Indivior Announces Proposed Convertible Senior Notes Offering
Mar 11, 2026
New Study Shows Adherence to Monthly Injectable Buprenorphine Linked to Lower Healthcare Utilization and Costs in Opioid Use Disorder

INDV Latest SEC Filings

Mar 27, 2026
[DEF 14A] Indivior Pharmaceuticals, Inc. Definitive Proxy Statement
Mar 23, 2026
[SCHEDULE 13G] Indivior Pharmaceuticals, Inc. Passive Investment Disclosure (>5%)
Mar 17, 2026
[Form 4] Indivior Pharmaceuticals, Inc. Insider Trading Activity
Mar 17, 2026
[8-K] Indivior Pharmaceuticals, Inc. Reports Material Event
Mar 13, 2026
[Form 4] Indivior Pharmaceuticals, Inc. Insider Trading Activity

INDV Stock Data

3.51B
120.07M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
NORTH CHESTERFIELD